BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  ASCO2016: Pfizer Presents Data From Phase Ib Trial Investigating Utomilumab (A 4-1BB Agonist) In Combination With A Checkpoint Inhibitor

  June 6, 2016

   · 

  8 min read
• Genetown

  ASCO2016: Foundation Medicine, Inc. Release: FoundationOne Identifies Patients With Advanced Lung Cancer Likely To Respond Or Develop Resistance To Certain RET Inhibitor Therapies

  June 6, 2016

   · 

  7 min read
• Drug Development

  Polaris Group Reports Phase III Study Results Of ADI-PEG 20 Plus Best Supportive Care In Advanced Hepatocellular Carcinoma

  June 6, 2016

   · 

  3 min read
• BioMidwest

  ASCO2016: Adaptive Biotech And Collaborators To Present Seven Studies Demonstrating The Use Of Immunosequencing To Identify Prognostic Biomarkers And Potential Biomarkers Of Response At The 2016 American Society Of Clinical Oncology Annual Meeting

  June 6, 2016

   · 

  4 min read
• Elsevier, Inc. Selected To Publish Open Access Journal Of Ayurveda And Integrative Medicine

  June 6, 2016

   · 

  4 min read
• Pharm Country

  Getinge Launches New “Harvesting Heroes” Campaign In Collaboration With APACVS To Recognize Healthcare Professionals In Heart Surgery

  June 6, 2016

   · 

  3 min read
• Drug Development

  ASCO2016 : AbbVie Presents Encouraging Phase 1 Data For Investigational Medicine ABT-414 As Monotherapy In Patients With An Aggressive Brain Cancer At The 2016 American Society Of Clinical Oncology Annual Meeting

  June 6, 2016

   · 

  8 min read
• Pharm Country

  ASCO2016: Novartis Pharmaceuticals Corporation Data Show More Than 50 Percent Of Eligible Ph+ CML Patients Maintain Treatment-Free Remission (TFR) After Stopping Tasigna

  June 6, 2016

   · 

  18 min read
• FDA

  Allergan Announces FDA Approval Of BYVALSON (Nebivolol And Valsartan)

  June 6, 2016

   · 

  12 min read
• Business

  Medgenics, Inc. Obtains Rights To First-In-Class Biologic For Severe Pediatric Onset IBD

  June 6, 2016

   · 

  10 min read